Evidence map›Paper›PMID 41388153›Full record

Observational studyNature immunology2026

Long COVID involves activation of proinflammatory and immune exhaustion pathways.

Malika Aid, Valentin Boero-Teyssier, Katherine McMahan, Rammy Dang, Michael Doyle, Nazim Belabbaci, Erica Borducchi, Ai-Ris Y Collier, Janet Mullington, Dan H Barouch

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. VSL#3British journal of biomedical science · 2026
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. SARS-CoV-2 and reproductive system: a scientometric study.Frontiers in reproductive health · 2026
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Malika AidCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-4498-7893
Valentin Boero-TeyssierCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Katherine McMahanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Rammy DangDivision of Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0003-4014-6429
Michael DoyleDivision of Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Nazim BelabbaciCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Erica BorducchiCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Ai-Ris Y CollierCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-8539-3960
Janet MullingtonDivision of Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-9156-9424
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.ORCID 0000-0001-5127-4659

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Irene M. Ghobrial · 1985 to 2026
$330.6M
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseU01CA260476 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BAROUCH, DAN H. · 2020 to 2024
$3.7M
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory UniversityS10OD026799 · OD · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD · 2019 to 2019
$985k
Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV-027406, INV-041469Gates Foundation INV-027406NCI NIH HHS P30 CA006516NCI NIH HHS U01 CA260476NIH HHS P51 OD011132NIH HHS S10 OD026799U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA260476
6 · The paper itself

Abstract

Long COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome coronavirus 2 infection. Current hypotheses for the pathogenesis of LC include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation. We performed immunological, virological, transcriptomic and proteomic analyses from a cohort of 142 individuals between 2020 and 2021, including uninfected controls (n = 35), acutely infected individuals (n = 54), convalescent controls (n = 24) and patients with LC (n = 28). The LC group was characterized by persistent immune activation and proinflammatory responses for more than 180 days after initial infection compared with convalescent controls, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways. Similar findings were observed in a second cohort enrolled between 2023 and 2024, including convalescent controls (n = 20) and patients with LC (n = 18). These data suggest that LC is characterized by persistent activation of chronic inflammatory pathways, suggesting new therapeutic targets and potential biomarkers of disease.

Indexed as

Immune System ExhaustionLymphocyte ActivationPost-Acute COVID-19 SyndromeSARS-CoV-2Signal TransductionAgedBiomarkersCase-Control StudiesConvalescenceFemaleHumansInflammationMaleMiddle AgedProteomeTranscriptomeBiomarkersProteome

Identifiers

PMID41388153
PMCPMC12764429

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.